Key terms
About ESTA
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ESTA news
Apr 15
7:35am ET
Establishment Labs price target raised to $62 from $53 at BTIG
Apr 03
5:52am ET
Establishment Labs price target raised to $60 from $49 at Citi
Apr 03
5:32am ET
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)
Apr 02
11:26am ET
Establishment Labs says FDA schedules preapproval inspection for Motiva facility
Apr 02
10:49am ET
Establishment Labs participates in a conference call with JPMorgan
Apr 01
6:42am ET
Establishment Labs price target raised to $65 from $50 at Mizuho
Mar 20
12:15am ET
Establishment Labs Poised for Robust Growth with Motiva Expansion and Upcoming Market Entries
Mar 12
7:17am ET
Establishment Labs price target raised to $60 from $50 at TD Cowen
Mar 12
4:15am ET
Buy Rating Affirmed for Establishment Labs on Positive FDA Approval Progress and Strong GMP Preparedness
Mar 05
1:00am ET
New Regulation Risk for Establishment Labs Holdings – What’s the Latest?
Mar 01
6:13am ET
Establishment Labs price target raised to $49 from $32 at Citi
Mar 01
1:27am ET
Buy Rating Affirmed for ESTA on Solid Guidance and Favorable Market Dynamics
Feb 29
7:22am ET
Establishment Labs price target raised to $53 from $45 at BTIG
Feb 29
6:38am ET
Establishment Labs Holdings: A Promising Buy Rating with Strategic Growth and Market Expansion
Feb 28
10:25pm ET
Buy Rating Affirmed for Establishment Labs on Strong Guidance and Positive Regulatory Outlook
Feb 28
4:01pm ET
Establishment Labs reports Q4 EPS (79c), consensus (91c)
Feb 22
4:43pm ET
Establishment Labs Amends Credit Terms with Oaktree Fund
Feb 22
3:45pm ET
Establishment Labs: Strategic Financial Moves and Pathway to Profitability Earn Buy Rating
Feb 13
3:15pm ET
Market Opportunity and Strong Product Offering Prompt ‘Buy’ Rating for Establishment Labs
Jan 26
2:15pm ET
Buy Rating for Establishment Labs: Anticipated Recovery and Product Launches Signal Strong Potential
Jan 22
8:03am ET
Establishment Labs launches Motiva Implants in China
No recent press releases are available for ESTA
ESTA Financials
Key terms
Ad Feedback
ESTA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ESTA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
